UNSPSC 51182077: Testosterone undecylate

This classification denotes a therapeutic testosterone with the molecular formula C30H48O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H16A5VCT9C, chemically known as 5-alpha-androstan-3-one, 17-beta-hydroxy-, undecanoate but more generally known as testosterone undecanoate, which bears US NIH Compound Identifier 65157. European Medicines Agency schedules Testosterone undecanoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04744MIG.

Most nations, for tariff and trade purposes, schedule testosterone undecylate under HS 29372900. SMILES: CCCCCCCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C.

UNSPSC 51182077 Testosterone undecylate, a Commodity code, covers a synthetic anabolic steroid used in clinical hormone-replacement and endocrinological treatment settings. State and local governments procure this pharmaceutical under the code primarily through health departments, correctional facilities, and public health agencies that provide medical services to inmates, patients in custody, and vulnerable populations. The product is a controlled substance requiring DEA licensing and strict chain-of-custody documentation; procurement typically occurs through competitive pharmaceutical bidding processes that emphasize price stability, supply reliability, and compliance with federal scheduling requirements. Issuing bodies include state departments of corrections, state health agencies, and county detention facilities that manage medical formularies for captive patient populations.

The source provides no recent opportunities posted under this code. Without visibility into active solicitation activity, geographic spread cannot be characterized. Procurement of controlled pharmaceutical substances under UNSPSC 51182077 remains opaque in public notice databases; vendors should confirm directly with state corrections departments and public health procurement offices whether opportunities in this category are issued through cooperative purchasing vehicles, blanket purchase orders, or non-public health-system formulary agreements rather than traditional RFP or IFB channels.